Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
Clinical trial NCT01289990 · COMPLETED
Trial details
- NCT number
- NCT01289990
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-05-01
- Enrollment
- 2705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.